Form 4: Bio-Rad Laboratories Executive Exercises Options and Sells Shares
SEC Form 4 Filing
Michael Crowley, EVP at Bio-Rad Laboratories, exercised stock options and sold shares on February 27, 2024.
Summary
- On February 27, 2024, Michael Crowley, EVP of Global Commercial Operations at Bio-Rad Laboratories, exercised non-qualified stock options to acquire 3,000 shares of Bio-Rad A Common Stock at a price of $215.98 per share.
- Following the exercise of these options, Crowley sold 3,000 shares at a weighted average price of $336, with individual sales ranging from $335.53 to $336.20.
- After these transactions, Crowley directly owns 6,942 shares of Bio-Rad A Common Stock.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of insider trading activity.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives, which is a standard practice in publicly traded companies.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies, ensuring transparency in insider trading activities.
- Executives at comparable companies like Thermo Fisher Scientific, Danaher, and Agilent Technologies also routinely file Form 4s to report similar transactions.
Stakeholder Impact
- The transaction could have a minor impact on shareholders due to the change in ownership, but it's unlikely to be significant given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| 09/05/2018 | Date on which the option was granted, with exercisability in five equal annual installments beginning on the first anniversary. |
| 09/05/2027 | Expiration date of the non-qualified stock option. |
| 02/27/2024 | Date of the transaction: exercise of stock options and sale of shares. |
| 02/28/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.